Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes (Q33838920)

29 July 2017

1 reference

title

Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes (English)

1 reference

29 July 2017

main subject

acute coronary syndrome

1 reference

A S Mathis

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Annals of Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

34

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

208-227

1 reference

Unmet therapeutic needs in the management of acute ischemia

29 July 2017

cites work

1 reference

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

21 January 2018

1 reference

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

Vulnerable plaque: pathobiology and clinical implications

21 January 2018

1 reference

Conventional antithrombotic approaches.

21 January 2018

1 reference

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor

21 January 2018

1 reference

Role of platelets in restenosis after percutaneous coronary revascularization

21 January 2018

1 reference

Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?

21 January 2018

1 reference

The Prognostic Value of Serum Troponin T in Unstable Angina

21 January 2018

1 reference

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

21 January 2018

1 reference

Unstable Angina : An Etiologic Approach to Management

21 January 2018

1 reference

The use of empiric clinical data in the evaluation of practice guidelines for unstable angina

21 January 2018

1 reference

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

21 January 2018

1 reference

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

21 January 2018

1 reference

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial

21 January 2018

1 reference

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

21 January 2018

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

21 January 2018

1 reference

Reactivation of unstable angina after the discontinuation of heparin

21 January 2018

1 reference

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

21 January 2018

1 reference

Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study

21 January 2018

1 reference

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

21 January 2018

1 reference

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

21 January 2018

1 reference

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

21 January 2018

1 reference

What role for catheter laboratories in unstable angina?

21 January 2018

1 reference

Low-molecular-weight heparins

21 January 2018

1 reference

Low-molecular-weight heparins for acute coronary syndromes

21 January 2018

1 reference

Low-molecular-weight heparin : A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina

21 January 2018

1 reference

Clinical trial results with hirudin and bivalirudin for acute coronary artery syndromes

21 January 2018

1 reference

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

Tirofiban. A review of its use in acute coronary syndromes

21 January 2018

1 reference

Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention

21 January 2018

1 reference

Clinical pharmacology of eptifibatide

21 January 2018

1 reference

Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease

21 January 2018

1 reference

Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.

21 January 2018

1 reference

Platelet GPIIb-IIIa blockers

21 January 2018

1 reference

New therapies for unstable angina and non-Q-wave myocardial infarction: recent clinical trials

21 January 2018

1 reference

Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.

21 January 2018

1 reference

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

21 January 2018

1 reference

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

21 January 2018

1 reference

Reactivation of the coagulation system: rationale for long-term antithrombotic treatment

21 January 2018

1 reference

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

21 January 2018

1 reference

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

21 January 2018

1 reference

The future of antithrombotic and antiplatelet therapy for ischemic heart disease

21 January 2018

1 reference

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

21 January 2018

1 reference

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

21 January 2018

1 reference

Platelet-active drugs: the relationships among dose, effectiveness, and side effects

21 January 2018

1 reference

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

21 January 2018

1 reference

Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I.

21 January 2018

1 reference

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost

21 January 2018

1 reference

Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.

21 January 2018

1 reference

Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19035

1 reference

29 July 2017

1 reference